Literature DB >> 27296897

Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.

Frank Fabris1,2, Yuankun Yue1, Yongxia Qu1,2, Mohamed Chahine3, Eric Sobie4, Peng Lee5,6, Rosemary Wieczorek5, Xian-Cheng Jiang1,7, Pier-Leopoldo Capecchi8, Franco Laghi-Pasini8, Pietro-Enea Lazzerini8, Mohamed Boutjdir9,10,11,12,13.   

Abstract

KEY POINTS: Channelopathies of autoimmune origin are novel and are associated with corrected QT (QTc) prolongation and complex ventricular arrhythmias. We have recently demonstrated that anti-SSA/Ro antibodies from patients with autoimmune diseases and with QTc prolongation on the ECG target the human ether-à-go-go-related gene (HERG) K+ channel by inhibiting the corresponding current, IKr , at the pore region. Immunization of guinea-pigs with a peptide (E-pore peptide) corresponding to the extracellular loop region connecting the S5 and S6 segments of the HERG channel induces high titres of antibodies that inhibit IKr , lengthen the action potential and cause QTc prolongation on the surface ECG. In addition, anti-SSA/Ro-positive sera from patients with connective tissue diseases showed high reactivity to the E-pore peptide. The translational impact is the development of a peptide-based approach for the diagnosis and treatment of autoimmune-associated long QT syndrome. ABSTRACT: We recently demonstrated that anti-SSA/52 kDa Ro antibodies (Abs) from patients with autoimmune diseases and corrected QT (QTc) prolongation directly target and inhibit the human ether-à-go-go-related gene (HERG) K+ channel at the extracellular pore (E-pore) region, where homology with SSA/52 kDa Ro antigen was demonstrated. We tested the hypothesis that immunization of guinea-pigs with a peptide corresponding to the E-pore region (E-pore peptide) will generate pathogenic inhibitory Abs and cause QTc prolongation. Guinea-pigs were immunized with a 31-amino-acid peptide corresponding to the E-pore region of HERG. On days 10-62 after immunization, ECGs were recorded and blood was sampled for the detection of E-pore peptide Abs. Serum samples from patients with autoimmune diseases were evaluated for reactivity to E-pore peptide by enzyme-linked immunosorbent assay (ELISA), and histology was performed on hearts using Masson's Trichrome. Inhibition of the HERG channel was assessed by electrophysiology and by computational modelling of the human ventricular action potential. The ELISA results revealed the presence of high titres of E-pore peptide Abs and significant QTc prolongation after immunization. High reactivity to E-pore peptide was found using anti-SSA/Ro Ab-positive sera from patients with QTc prolongation. Histological data showed no evidence of fibrosis in immunized hearts. Simulations of simultaneous inhibition of repolarizing currents by anti-SSA/Ro Ab-positive sera showed the predominance of the HERG channel in controlling action potential duration and the QT interval. These results are the first to demonstrate that inhibitory Abs to the HERG E-pore region induce QTc prolongation in immunized guinea-pigs by targeting the HERG channel independently from fibrosis. The reactivity of anti-SSA/Ro Ab-positive sera from patients with connective tissue diseases with the E-pore peptide opens novel pharmacotherapeutic avenues in the diagnosis and management of autoimmune-associated QTc prolongation. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  HERG channel; Immunization; Long QT syndrome; autoimmune diseases

Mesh:

Substances:

Year:  2016        PMID: 27296897      PMCID: PMC5088251          DOI: 10.1113/JP272151

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  41 in total

1.  Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.

Authors:  T Christ; E Wettwer; D Dobrev; E Adolph; M Knaut; G Wallukat; U Ravens
Journal:  J Mol Cell Cardiol       Date:  2001-08       Impact factor: 5.000

2.  Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome.

Authors:  Kazufumi Nakamura; Yusuke Katayama; Kengo F Kusano; Kayo Haraoka; Yoshinori Tani; Satoshi Nagase; Hiroshi Morita; Daiji Miura; Yoshihisa Fujimoto; Tetsushi Furukawa; Kazuo Ueda; Yoshiyasu Aizawa; Akinori Kimura; Yoshihisa Kurachi; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2007-10-30       Impact factor: 24.094

3.  Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block.

Authors:  M Boutjdir; L Chen; Z H Zhang; C E Tseng; F DiDonato; W Rashbaum; A Morris; N el-Sherif; J P Buyon
Journal:  Circ Res       Date:  1997-03       Impact factor: 17.367

Review 4.  Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Francesca Guideri; Maurizio Acampa; Enrico Selvi; Stefania Bisogno; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Basic Res Cardiol       Date:  2007-11-12       Impact factor: 17.165

5.  Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Francesca Guideri; Francesca Bellisai; Enrico Selvi; Maurizio Acampa; Agnese Costa; Roberta Maggio; Estrella Garcia-Gonzalez; Stefania Bisogno; Gabriella Morozzi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Am J Cardiol       Date:  2007-07-06       Impact factor: 2.778

6.  Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1.

Authors:  H Swan; K Saarinen; K Kontula; L Toivonen; M Viitasalo
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

7.  Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy.

Authors:  Jin Li; Claudia Seyler; Felix Wiedmann; Constanze Schmidt; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Cardiovasc Res       Date:  2013-02-27       Impact factor: 10.787

8.  Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.

Authors:  L Strandberg; O Winqvist; S-E Sonesson; S Mohseni; S Salomonsson; K Bremme; J P Buyon; H Julkunen; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

9.  Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model.

Authors:  M Boutjdir; L Chen; Z H Zhang; C E Tseng; N El-Sherif; J P Buyon
Journal:  Pediatr Res       Date:  1998-07       Impact factor: 3.756

Review 10.  Long QT Syndrome: An Emerging Role for Inflammation and Immunity.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Front Cardiovasc Med       Date:  2015-05-27
View more
  6 in total

Review 1.  QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics.

Authors:  Sanjay Chandrasekhar; Michael G Fradley
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

2.  Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression.

Authors:  John Szendrey; Shawn M Lamothe; Stephanie Vanner; Jun Guo; Tonghua Yang; Wentao Li; Jordan Davis; Mala Joneja; Adrian Baranchuk; Shetuan Zhang
Journal:  Cardiovasc Res       Date:  2019-08-01       Impact factor: 10.787

Review 3.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

4.  Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Lupus Sci Med       Date:  2016-12-08

Review 5.  Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Nabil El-Sherif; Franco Laghi-Pasini; Mohamed Boutjdir
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 6.  Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes.

Authors:  Timothy Cardozo; Lila Cardozo; Mohamed Boutjdir
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.